United States · FDA National Drug Code directory
oxcarbazepine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 33342-259_962098cc-2d84-4723-a296-b110f1fd659e
- Product NDC
- 33342-259
- Form
- FOR SUSPENSION
- Composition / generic term
- oxcarbazepine
- Labeler
- Macleods Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250711
- Source listing expiry
- 20261231
Source-listed ingredients
- OXCARBAZEPINE — 300 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (33342-259-67) / 250 mL in 1 BOTTLE · 33342-259-67
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →